# Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)

> **NCT03057470** · PHASE4 · UNKNOWN · sponsor: **LMC Diabetes & Endocrinology Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** 50% bolus insulin correction
- **DRUG:** 100% bolus insulin correction
- **DRUG:** 150% bolus insulin correction
- **OTHER:** 0% bolus insulin correction

## Key facts

- **NCT ID:** NCT03057470
- **Lead sponsor:** LMC Diabetes & Endocrinology Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2017-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057470, "Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03057470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*